DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Copaxone (Glatiramer Acetate) - Current Clinical Trials

 
 



Copaxone Related Clinical Trials

Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation [Active, not recruiting]

Treatment of Multiple Sclerosis With Copaxone and Albuterol [Active, not recruiting]

Efficacy and Safety of GTR in Comparison to Copaxone� [Recruiting]

Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate Therapy to Glatiramer Acetate Monotherapy for MS [Recruiting]

A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease [Recruiting]

A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis. [Completed]

Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness. [Active, not recruiting]

Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients [Recruiting]

MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone [Recruiting]

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis [Recruiting]

Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA) [Recruiting]

Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS) [Recruiting]

A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis [Completed]

Copaxone in Age Related Macular Degeneration [Recruiting]

Simvastatin as an Add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis [Not yet recruiting]

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®. [Completed]

Phase IV, Rater-Blinded, Randomized Study, Comparing the Effects of 250 Mg of Betaseron With 20 Mg of Copaxone in Patients With the Relapsing-Remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-Dose Gadolinium [Active, not recruiting]

A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months [Recruiting]

Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-Related Macular Degeneration [Recruiting]

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose [Completed]

A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone® [Completed]

High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis [Not yet recruiting]

An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis [Terminated]

A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone [Completed]

Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate [Active, not recruiting]

A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) [Recruiting]

FOCUS Fatigue Outcome in Copaxone USers [Active, not recruiting]

Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline [Completed]

A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo [Recruiting]

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis [Completed]

Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA). [Active, not recruiting]

The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections [Not yet recruiting]

Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate [Recruiting]

Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis [Recruiting]

Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients With Multiple Sclerosis Taking Glatiramer Acetate [Recruiting]

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®. [Completed]

fMRI Study of Treatment Recommendations Comparing Recently Diagnosed MS Patients to Controls [Recruiting]

A Study to Evaluate the Effect of Early Glatiramer Acetate Treatment in Delaying the Conversion to CDMS of Subjects Presenting With a Clinically Isolated Syndrome (CIS) [Active, not recruiting]

Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS) [Completed]

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon) [Recruiting]

Pilot Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis [Recruiting]

Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities [Recruiting]

A Prospective Study of Spasticity in Individuals With Multiple Sclerosis [Recruiting]

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose [Active, not recruiting]

Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine [Completed]

Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS [Completed]

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose [No longer recruiting]

Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx [Recruiting]

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis [Completed]

Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis [Completed]

The Rebif vs Glatiramer Actetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial [Recruiting]

Therapy Optimization in Multiple Sclerosis (MS) [Recruiting]

Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects [Terminated]

Stem Cell Therapy for Patients With Multiple Sclerosis Failing Interferon A Randomized Study [Recruiting]

Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis [Recruiting]

A Study to Evaluate Readiness to Self-Inject on Adherence and Compliance to Copaxone® Therapy [Completed]

Alternative Treatment Paradigm for Natalizumab Trial [Not yet recruiting]

Treatment Interruption of Natalizumab [Recruiting]

Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis [Not yet recruiting]

Vitamin D Supplementation in Multiple Sclerosis [Recruiting]

Patients With RRMS:Candidates for MS Therapy Change [Recruiting]

Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control [Recruiting]

BG00012 Phase 2 Combination Study in Subjects With Multiple Sclerosis [Recruiting]

Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy [Recruiting]

Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis [Not yet recruiting]

Cognitive Effects of Immunomodulatory Drugs in MS [Active, not recruiting]

Mindfulness Based Stress Reduction in Multiple Sclerosis (MS) [Recruiting]

Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study) [Recruiting]

Neuroprotection and Repair in Optic Neuritis [Recruiting]

Natalizumab Re-Initiation of Dosing [Active, not recruiting]

Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis [Active, not recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014